Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Charlie Hospital Semarang Tbk. (RSCH) vs Sinergi Multi Lestarindo Tbk. (SMLE) Price & Performance

Charlie Hospital Semarang Tbk.Trade
Sinergi Multi Lestarindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Charlie Hospital Semarang Tbk. vs Sinergi Multi Lestarindo Tbk. — how do they compare? Charlie Hospital Semarang Tbk. trades at Rp308 (market cap 821.5B, 12.68M 24h volume), while Sinergi Multi Lestarindo Tbk. trades at Rp174 (market cap 412.08B, 13.3M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Sinergi Multi Lestarindo Tbk. is more actively traded (13.3M versus 12.68M). Which is the better fit depends on your goals.

RSCHSMLE
Market Cap
821.5B412.08B
Volume
12.68M13.3M
Lot
126.75K132.97K
Turnover
3.92B2.3B
Average Price
309.23172.61
Value
3.92B2.3B
Indicative Equilibrium Price
312174
Indicative Equilibrium Volume
101.06K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RSCH
View details
SMLE
View details

About Charlie Hospital Semarang Tbk.

PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.

Read more on RSCH

About Sinergi Multi Lestarindo Tbk.

PT Sinergi Multi Lestarindo Tbk (the Company) was established based on Deed No. 5 dated March 18, 2013 by Aryadi, S.H., M.Kn., Notary in Tangerang. PT Sinergi Asia Corporindo is the parent entity of the Company and Siu Min is the ultimate beneficiary owner of the Company.

Read more on SMLE